Registration of financial instruments

BSE Board of Directors adopted the following decision at a session held under Record of Proceedings No. 76 of 25 September 2025:
With reference to a Resolution of the FSC under No. 587-E of 24 September 2025 regarding the entry of a subsequent issue of shares of Tchaikapharma High Quality Medicines AD in the Register of Public Companies and Other Securities Issuers under Art. 30 (1), item 3 of the FSC Act, BSE Board of Directors admits to trading on the Standard Equities Segment of the BSE Main Market a subsequent issue of shares on the grounds of Art. 35 (8) in conjunction with Art. 21 of Part III - Listing Rules, as follows:
- Issuer: Tchaikapharma High Quality Medicines AD
- ISIN of the issue: BG1100008074
- BSE code of the issue: THQM
- Amount of the issue before the increase: BGN 91,800,000
- Amount of the increase: BGN 4,100,000
- Amount of the issue following the increase: BGN 95,900,000
- Number of shares following the increase: 95,900,000 shares
- Nominal value per share: BGN 1.00 /one Bulgarian lev/
- Type of shares: Ordinary, registered, dematerialised and voting shares
- Starting date of trading: 26 September 2025 (Friday)